Markers of pancreatic cancer stem cells and their clinical and therapeutic implications
- PMID: 31486978
- DOI: 10.1007/s11033-019-05058-1
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications
Abstract
Pancreatic cancer (PC) is the fourth most common cause of death among all cancers. Poor prognosis of PC may be caused by a prevalence of cancer stem cells (CSCs). CSCs are a population of cancer cells showing stem cell-like characteristics. CSCs have the ability to self-renew and may initiate tumorigenesis. PC CSCs express markers such as CD133, CD24, CD44, DCLK1, CXCR4, ESA, Oct4 and ABCB1. There is a wide complexity of interaction and relationships between CSC markers in PC. These markers are negative prognostic factors and are connected with tumor recurrence and clinical progression. Additionally, PC CSCs are resistant to treatment with gemcitabine. Thus, most current therapies for PC are ineffective. Numerous studies have shown, that targeting of these proteins may increase both disease-free and overall survival in PC.
Keywords: Cancer stem cells; Pancreatic cancer; Prognostic factors.
Similar articles
-
Pancreatic cancer stem cells: emerging target for designing novel therapy.Cancer Lett. 2013 Sep 10;338(1):94-100. doi: 10.1016/j.canlet.2012.03.018. Epub 2012 Mar 20. Cancer Lett. 2013. PMID: 22445908 Free PMC article. Review.
-
Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer.Stem Cell Res Ther. 2015 Sep 22;6(1):182. doi: 10.1186/s13287-015-0173-3. Stem Cell Res Ther. 2015. PMID: 26395574 Free PMC article.
-
Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.PLoS One. 2011 Jan 31;6(1):e16530. doi: 10.1371/journal.pone.0016530. PLoS One. 2011. PMID: 21304978 Free PMC article.
-
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.Int J Cancer. 2018 Sep 1;143(5):1162-1175. doi: 10.1002/ijc.31400. Epub 2018 Apr 16. Int J Cancer. 2018. PMID: 29577277 Free PMC article.
-
Cancer stem cell in the progression and therapy of pancreatic cancer.Front Biosci (Landmark Ed). 2013 Jun 1;18(3):795-802. doi: 10.2741/4143. Front Biosci (Landmark Ed). 2013. PMID: 23747847 Review.
Cited by
-
Hypoxia: a barricade to conquer the pancreatic cancer.Cell Mol Life Sci. 2020 Aug;77(16):3077-3083. doi: 10.1007/s00018-019-03444-3. Epub 2020 Jan 6. Cell Mol Life Sci. 2020. PMID: 31907561 Free PMC article. Review.
-
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance.Cancer Metastasis Rev. 2021 Sep;40(3):691-720. doi: 10.1007/s10555-021-09979-x. Epub 2021 Aug 28. Cancer Metastasis Rev. 2021. PMID: 34453639 Free PMC article. Review.
-
Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance.Front Oncol. 2021 Jun 14;11:683788. doi: 10.3389/fonc.2021.683788. eCollection 2021. Front Oncol. 2021. PMID: 34195085 Free PMC article. Review.
-
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review).Int J Oncol. 2022 Aug;61(2):93. doi: 10.3892/ijo.2022.5383. Epub 2022 Jun 22. Int J Oncol. 2022. PMID: 35730611 Free PMC article. Review.
-
The CXCL12 Crossroads in Cancer Stem Cells and Their Niche.Cancers (Basel). 2021 Jan 26;13(3):469. doi: 10.3390/cancers13030469. Cancers (Basel). 2021. PMID: 33530455 Free PMC article. Review.
References
-
- Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer L Clin 67:7–30. https://doi.org/10.3322/caac.21387 - DOI
-
- World Cancer Report (2014) World Health Organization 2014. Chapter 5.7. ISBN 978-92-832-0429-9
-
- De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13(2):97 - DOI
-
- Krejs GJ (2010) Pancreatic cancer: epidemiology and risk factors. Dig Dis 28:355–358. https://doi.org/10.1159/000319414 - DOI - PubMed
-
- Maisonneuve P, Lowenfels AB (2014) Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol 44(1):186–198 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous